Cancer Progress

Communitech's Cancer Progress, the premier annual cancer conference for pharmaceutical and biotechnology executives, features presentations and panel discussions on concepts critical to drug development and commercialization.

Forty leading scientists and executives will address emerging targets, combination therapies, translational research, autophagy, biomarkers and much more plus attrition rates, reimbursement and innovative business models.